Last €3.33 EUR
Change Today +0.05 / 1.52%
Volume 0.0
As of 3:24 AM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

resmed inc-cdi (RMEA) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/15/13 - €4.10
52 Week Low
03/25/14 - €3.05
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for RESMED INC-CDI (RMEA)

resmed inc-cdi (RMEA) Related Bloomberg News

View More Bloomberg News

resmed inc-cdi (RMEA) Related Businessweek News

No Related Businessweek News Found

resmed inc-cdi (RMEA) Details

ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. It offers various products, including airflow generators, diagnostic products, mask systems, headgear products, and ventilation devices for the treatment of sleep-disordered breathing that includes obstructive sleep apnea and other respiratory disorders, as well as other optional accessories, such as cold passover humidifiers, carry bags, and breathing circuits. The company also provides data communications and control products consisting of EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators, as well as humidifiers, which connect with the continuous and variable positive airway pressure, and autoset flow generators. ResMed Inc. markets its products to sleep clinics, home healthcare dealers, and third-party payers. The company sells its products through a network of distributors and direct sales force in approximately 100 countries worldwide. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

3,900 Employees
Last Reported Date: 08/13/13
Founded in 1989

resmed inc-cdi (RMEA) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $511.2K
President and Chief Operating Officer
Total Annual Compensation: $588.8K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $505.3K
President of SDB Strategic Business Unit
Total Annual Compensation: $385.0K
President of Americas
Total Annual Compensation: $379.8K
Compensation as of Fiscal Year 2013.

resmed inc-cdi (RMEA) Key Developments

ResMed Mulls Partners

ResMed Inc. (NYSE:RMD) is seeking partners. ResMed is now looking for an electronics partner to work with to produce the devices, which will not require a prescription to buy, Mick Farrell, Chief Executive Officer of ResMed, said, The Australian Financial Review reported.

ResMed Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-08-2014 12:10 PM

ResMed Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-08-2014 12:10 PM. Venue: The Westin Grand Central Hotel, New York, New York, United States.

ResMed Inc. Presents at Barclays Capital 2014 Global Healthcare Conference, Mar-13-2014 08:00 AM

ResMed Inc. Presents at Barclays Capital 2014 Global Healthcare Conference, Mar-13-2014 08:00 AM. Venue: Loews Miami Beach Hotel, Miami, Florida, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RMEA:GR €3.33 EUR +0.05

RMEA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
IDEXX Laboratories Inc $118.45 USD +0.31
MEDNAX Inc $59.91 USD -0.06
Mettler-Toledo International Inc $228.54 USD +3.55
Teleflex Inc $102.48 USD +0.08
Cooper Cos Inc/The $127.35 USD +0.68
View Industry Companies

Industry Analysis


Industry Average

Valuation RMEA Industry Range
Price/Earnings 21.0x
Price/Sales 4.3x
Price/Book 4.0x
Price/Cash Flow 19.8x
TEV/Sales 3.4x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESMED INC-CDI, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at